OSCR
Oscar Health, Inc. NYSE Listed Mar 3, 2021$20.88
Mkt Cap $5.4B
52w Low $10.69
77.7% of range
52w High $23.80
50d MA $14.51
200d MA $16.01
P/E (TTM)
-10.9x
EV/EBITDA
-3.6x
P/B
5.0x
Debt/Equity
0.4x
ROE
-45.3%
P/FCF
3.6x
RSI (14)
—
ATR (14)
—
Beta
1.93
50d MA
$14.51
200d MA
$16.01
Avg Volume
7.3M
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
75 Varick Street · New York City, NY 10013 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | TNS | 1.11 | 2.07 | +86.5% | 19.84 | -0.3% | +5.2% | — | — | — | — | — |
| Feb 10, 2026 | TNS | -0.92 | -1.24 | -34.6% | 12.88 | +2.5% | +5.6% | +6.4% | +4.2% | +4.0% | +6.4% | — |
| Nov 6, 2025 | TNS | -0.55 | -0.53 | +3.6% | 16.56 | -0.8% | +7.0% | -11.8% | -10.3% | -8.8% | -15.8% | — |
| Aug 6, 2025 | TNS | -0.90 | -0.89 | +1.1% | 14.34 | +0.9% | +5.7% | +7.8% | +8.9% | +4.5% | +4.1% | — |
| May 7, 2025 | TNS | 0.83 | 0.92 | +10.8% | 17.02 | +3.2% | +0.2% | +0.5% | -1.2% | -0.6% | -2.8% | — |
| Feb 4, 2025 | TNS | -0.55 | -0.62 | -12.7% | 15.28 | -1.7% | +3.1% | -3.3% | -3.8% | -3.7% | -7.7% | — |
| Nov 7, 2024 | TNS | -0.20 | -0.22 | -10.0% | 13.64 | -0.2% | -0.7% | +1.2% | -0.6% | -1.2% | +13.2% | — |
| Aug 7, 2024 | TNS | 0.16 | 0.20 | +25.0% | 16.70 | +1.9% | +10.6% | +8.1% | +7.7% | +9.5% | +9.0% | — |
| May 7, 2024 | TNS | 0.27 | 0.62 | +129.6% | 19.77 | -0.6% | +4.9% | +12.2% | +9.5% | +11.0% | +15.5% | — |
| Feb 7, 2024 | TNS | -0.74 | -0.66 | +10.8% | 13.41 | +30.0% | +24.4% | +31.8% | +29.2% | +25.4% | +26.0% | — |
| Nov 7, 2023 | TNS | -0.47 | -0.29 | +38.3% | 6.62 | +3.0% | +6.5% | +2.0% | +7.4% | +2.7% | +8.6% | — |
| Aug 8, 2023 | TNS | -0.33 | -0.07 | +78.8% | 7.13 | +8.6% | +12.1% | +2.7% | +5.2% | -2.7% | +6.0% | — |
| May 9, 2023 | BMO | -0.05 | -0.18 | -254.6% | 7.14 | +3.2% | -3.9% | -2.4% | -1.7% | +0.6% | -4.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6 | Wolfe Research | Initiates | Peer Perform | — | $17.94 | $18.44 | +2.8% | +10.6% | +16.3% | — | — | — |
| Apr 20 | Jefferies | Upgrade | Underperform → Hold | — | $15.79 | $16.08 | +1.8% | +4.1% | +2.4% | +4.1% | +4.1% | +6.5% |
| Jan 9 | UBS | Upgrade | Sell → Neutral | — | $16.90 | $18.01 | +6.6% | +4.9% | +4.5% | +2.8% | -1.2% | +3.1% |
| Jan 5 | Barclays | Upgrade | Underweight → Equal Weight | — | $14.97 | $15.65 | +4.5% | +10.7% | +10.4% | +10.1% | +12.9% | +18.4% |
| Nov 26 | Piper Sandler | Upgrade | Neutral → Overweight | — | $16.73 | $17.59 | +5.1% | +8.5% | +7.4% | -0.5% | +0.7% | +2.2% |
| Nov 13 | Wells Fargo | Maintains | Underweight → Underweight | — | $15.10 | $14.80 | -2.0% | -7.6% | -8.1% | -5.6% | -2.6% | -6.8% |
| Nov 10 | Barclays | Maintains | Underweight → Underweight | — | $17.72 | $16.13 | -9.0% | -17.6% | -16.2% | -14.8% | -21.3% | -21.7% |
| Nov 7 | UBS | Maintains | Sell → Sell | — | $16.56 | $16.42 | -0.8% | +7.0% | -11.8% | -10.3% | -8.8% | -15.8% |
| Oct 7 | Wells Fargo | Maintains | Underweight → Underweight | — | $22.31 | $23.55 | +5.6% | +0.7% | -2.3% | -7.9% | -15.9% | -8.6% |
| Aug 14 | Piper Sandler | Maintains | Neutral → Neutral | — | $14.93 | $14.64 | -1.9% | -1.7% | +4.8% | +11.5% | +11.4% | +2.3% |
| Jul 25 | Baird | Downgrade | Outperform → Neutral | — | $14.20 | $14.28 | +0.6% | +1.8% | +3.3% | -2.5% | -1.4% | -1.1% |
| Jul 23 | Barclays | Maintains | Underweight → Underweight | — | $14.70 | $14.24 | -3.1% | +8.0% | -3.4% | -1.7% | -0.2% | -5.9% |
| Jul 15 | UBS | Downgrade | Neutral → Sell | — | $15.08 | $14.62 | -3.1% | -1.1% | +1.8% | -8.0% | -11.0% | -9.7% |
| Jul 11 | Wells Fargo | Downgrade | Equal Weight → Underweight | — | $15.53 | $14.99 | -3.5% | -7.4% | -2.9% | -3.9% | -1.2% | -10.7% |
| Jun 9 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.42 | $15.50 | +0.5% | -4.3% | -4.7% | -8.2% | -7.0% | -9.5% |
| Mar 13 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $14.19 | $13.60 | -4.2% | -9.2% | -6.8% | -5.2% | -9.6% | -9.4% |
| Nov 6 | BofA Securities | Downgrade | Neutral → Underperform | — | $18.34 | $15.79 | -13.9% | -15.2% | -25.6% | -26.2% | -24.8% | -26.1% |
| Sep 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $17.47 | $18.00 | +3.0% | -0.3% | +18.3% | +20.2% | +23.7% | +25.5% |
| Aug 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $16.70 | $17.01 | +1.9% | +10.6% | +8.1% | +7.7% | +9.5% | +9.0% |
| Jul 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.75 | $15.87 | +0.8% | +4.1% | +5.3% | +4.9% | +1.6% | +2.8% |
| Jun 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $20.01 | $20.60 | +2.9% | -4.7% | -5.0% | -5.0% | -6.0% | -3.9% |
| May 30 | BofA Securities | Downgrade | Buy → Neutral | — | $20.18 | $19.49 | -3.4% | -1.6% | -1.1% | -4.8% | -6.1% | -2.4% |
| May 20 | BofA Securities | Maintains | Buy → Buy | — | $22.52 | $22.51 | -0.0% | -2.3% | +3.4% | -1.3% | -6.9% | -8.7% |
| May 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $20.74 | $21.19 | +2.2% | +6.9% | +4.3% | +5.8% | +10.1% | +9.2% |
| May 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $20.74 | $21.19 | +2.2% | +6.9% | +4.3% | +5.8% | +10.1% | +9.2% |
| Feb 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $16.89 | $17.07 | +1.1% | +8.1% | +5.2% | +3.6% | +0.4% | -1.1% |
| Feb 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $16.68 | $16.49 | -1.1% | +6.0% | +3.9% | +0.8% | +1.3% | +9.4% |
| Feb 8 | BofA Securities | Maintains | Buy → Buy | — | $13.41 | $17.43 | +30.0% | +24.4% | +31.8% | +29.2% | +25.4% | +26.0% |
| Nov 2 | BofA Securities | Upgrade | Neutral → Buy | — | $4.98 | $5.73 | +15.1% | +10.6% | +15.1% | +14.7% | +32.9% | +41.6% |
| Aug 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $6.38 | $6.45 | +1.1% | -0.5% | -1.7% | +3.1% | -0.5% | +0.6% |
| Aug 10 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.99 | $7.89 | -1.3% | -8.4% | -6.1% | -13.1% | -5.4% | -7.5% |
| Aug 9 | Credit Suisse | Maintains | Outperform → Outperform | — | $7.13 | $7.74 | +8.6% | +12.1% | +2.7% | +5.2% | -2.7% | +6.0% |
| Jul 14 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.40 | $7.42 | +0.3% | +6.1% | +12.2% | +12.4% | +12.8% | +11.9% |
| Jun 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.25 | $9.53 | +3.0% | +4.0% | -1.2% | +3.5% | -4.3% | -4.2% |
| Jun 6 | BofA Securities | Upgrade | Underperform → Neutral | — | $8.30 | $8.40 | +1.2% | +7.1% | +7.2% | +6.7% | +10.8% | +11.4% |
| May 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $6.85 | $6.99 | +2.0% | +6.6% | +6.4% | +5.0% | +9.2% | +6.9% |
| May 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $7.14 | $7.37 | +3.2% | -3.9% | -2.4% | -1.7% | +0.6% | -4.1% |
| Mar 29 | BofA Securities | Maintains | Underperform → Underperform | — | $5.61 | $5.65 | +0.7% | +14.1% | +18.0% | +16.6% | +20.1% | +16.2% |
| Feb 14 | Cowen & Co. | Maintains | Market Perform → Market Perform | — | $5.29 | $5.24 | -0.9% | +5.3% | +7.8% | +6.0% | +5.9% | -0.4% |
| Feb 14 | Goldman Sachs | Maintains | Neutral → Neutral | — | $5.29 | $5.24 | -0.9% | +5.3% | +7.8% | +6.0% | +5.9% | -0.4% |
| Feb 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $3.80 | $3.90 | +2.6% | +30.3% | +39.2% | +46.6% | +50.0% | +47.6% |
| Nov 16 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $2.89 | $3.05 | +5.5% | +0.3% | -3.8% | -0.7% | +1.4% | -6.9% |
| Nov 14 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $2.95 | $2.97 | +0.7% | -4.1% | -2.0% | -1.7% | -5.8% | -2.7% |
| Sep 1 | Morgan Stanley | Maintains | Overweight → Overweight | — | $6.63 | $6.46 | -2.6% | -7.8% | -12.1% | -16.7% | -13.6% | -12.5% |
| Jun 15 | BofA Securities | Downgrade | Neutral → Underperform | — | $4.19 | $4.00 | -4.5% | +1.7% | -3.1% | +5.0% | +3.8% | +4.1% |
| Jun 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $5.22 | $5.15 | -1.3% | -6.3% | -12.5% | -17.6% | -19.7% | -18.4% |
| May 26 | BofA Securities | Downgrade | Buy → Neutral | — | $5.06 | $4.75 | -6.1% | -5.5% | +0.2% | -4.3% | -7.1% | -1.4% |
| Mar 28 | Morgan Stanley | Maintains | Overweight → Overweight | — | $9.54 | $9.48 | -0.6% | -4.8% | +6.5% | +7.4% | +4.5% | +6.3% |
| Feb 14 | Goldman Sachs | Upgrade | Sell → Neutral | — | $6.70 | $6.76 | +1.0% | -0.7% | +9.6% | +10.7% | +4.9% | +4.5% |
| Feb 14 | Morgan Stanley | Maintains | Overweight → Overweight | — | $6.70 | $6.76 | +1.0% | -0.7% | +9.6% | +10.7% | +4.9% | +4.5% |
No insider trades available.
8-K · 2.02
!! High
Oscar Health, Inc. -- 8-K 2.02: Earnings Results
Oscar Health reported quarterly earnings results, which are detailed in the attached press release and available for investor review regarding the company's operational performance and financial condition.
May 6
8-K · 7.01
! Medium
Oscar Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Oscar Health reaffirmed its May 6, 2026 earnings release and conference call schedule, providing investors with advance notice of when to expect first-quarter results and management commentary.
Apr 21
8-K
Oscar Health, Inc. -- 8-K Filing
Oscar Health's 8-K filing contains standard forward-looking statement disclaimers, indicating investors should review risk factors in the company's 10-K before making investment decisions.
Mar 2
8-K · 1.01
! Medium
Oscar Health, Inc. -- 8-K 1.01: Financing / Debt Agreement
Oscar Health's revolving credit facility will mature on February 6, 2029, requiring the company to refinance or repay any outstanding borrowings by that date.
Feb 10
Data updated apr 26, 2026 5:58pm
· Source: massive.com